175 related articles for article (PubMed ID: 21426127)
1. Finding order within disorder: elucidating the structure of proteins associated with neurodegenerative disease.
Huang A; Stultz CM
Future Med Chem; 2009 Jun; 1(3):467-82. PubMed ID: 21426127
[TBL] [Abstract][Full Text] [Related]
2. A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders.
Uversky VN
J Biomol Struct Dyn; 2003 Oct; 21(2):211-34. PubMed ID: 12956606
[TBL] [Abstract][Full Text] [Related]
3. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases.
Pawar AP; Dubay KF; Zurdo J; Chiti F; Vendruscolo M; Dobson CM
J Mol Biol; 2005 Jul; 350(2):379-92. PubMed ID: 15925383
[TBL] [Abstract][Full Text] [Related]
4. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
Meredith SC
Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of neurotoxic tau oligomers.
Lasagna-Reeves CA; Castillo-Carranza DL; Guerrero-Muoz MJ; Jackson GR; Kayed R
Biochemistry; 2010 Nov; 49(47):10039-41. PubMed ID: 21047142
[TBL] [Abstract][Full Text] [Related]
6. [Conformationally altered proteins cause neurodegenerative diseases].
Ingelsson M; Nilsson L; Basun H; Aquilonius SM; Lannfelt L
Lakartidningen; 2005 Nov 21-27; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392
[TBL] [Abstract][Full Text] [Related]
7. Single-molecule fluorescence studies of intrinsically disordered proteins.
Ferreon AC; Moran CR; Gambin Y; Deniz AA
Methods Enzymol; 2010; 472():179-204. PubMed ID: 20580965
[TBL] [Abstract][Full Text] [Related]
8. Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide.
Gadad BS; Britton GB; Rao KS
J Alzheimers Dis; 2011; 24 Suppl 2():223-32. PubMed ID: 21460436
[TBL] [Abstract][Full Text] [Related]
9. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
Rockenstein E; Crews L; Masliah E
Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins.
Linding R; Schymkowitz J; Rousseau F; Diella F; Serrano L
J Mol Biol; 2004 Sep; 342(1):345-53. PubMed ID: 15313629
[TBL] [Abstract][Full Text] [Related]
11. Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases.
Breydo L; Uversky VN
Metallomics; 2011 Nov; 3(11):1163-80. PubMed ID: 21869995
[TBL] [Abstract][Full Text] [Related]
12. Intrinsically disordered proteins in the neurodegenerative processes: formation of tau protein paired helical filaments and their analysis.
Skrabana R; Sevcik J; Novak M
Cell Mol Neurobiol; 2006; 26(7-8):1085-97. PubMed ID: 16779670
[TBL] [Abstract][Full Text] [Related]
13. Structures of the intrinsically disordered Aβ, tau and α-synuclein proteins in aqueous solution from computer simulations.
Nguyen PH; Derreumaux P
Biophys Chem; 2020 Sep; 264():106421. PubMed ID: 32623047
[TBL] [Abstract][Full Text] [Related]
14. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.
Uversky VN
J Neurochem; 2007 Oct; 103(1):17-37. PubMed ID: 17623039
[TBL] [Abstract][Full Text] [Related]
15. Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins.
El-Agnaf OM; Irvine GB
J Struct Biol; 2000 Jun; 130(2-3):300-9. PubMed ID: 10940234
[TBL] [Abstract][Full Text] [Related]
16. [Neurodegenerative conformational disease and its molecular bases].
Li WW; Cai DF; Ren HM
Sheng Li Ke Xue Jin Zhan; 2006 Apr; 37(2):97-102. PubMed ID: 16850610
[TBL] [Abstract][Full Text] [Related]
17. Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of alpha-synuclein aggregation.
van Ham TJ; Esposito A; Kumita JR; Hsu ST; Kaminski Schierle GS; Kaminski CF; Dobson CM; Nollen EA; Bertoncini CW
J Mol Biol; 2010 Jan; 395(3):627-42. PubMed ID: 19891973
[TBL] [Abstract][Full Text] [Related]
18. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
Goedert M
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
[TBL] [Abstract][Full Text] [Related]
19. Subcellular analysis of aberrant protein structure in age-related neurodegenerative disorders.
Mazzola JL; Sirover MA
J Neurosci Methods; 2004 Aug; 137(2):241-6. PubMed ID: 15262067
[TBL] [Abstract][Full Text] [Related]
20. A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins.
Joshi P; Chia S; Habchi J; Knowles TP; Dobson CM; Vendruscolo M
ACS Comb Sci; 2016 Mar; 18(3):144-53. PubMed ID: 26923286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
